By Sheri Kasprzak
Altanta, Nov. 5 - Resverlogix Corp. late Thursday announced pricing terms on its previously announced C$9 million private placement and said it may increase the offering to C$11 million.
The company will sell the equities at C$3 per share.
Resverlogix has also granted the option for placement agents First Associates Investments Inc., Haywood Securities Inc., Sprott Securities Inc. and Jennings Capital Inc. to increase the size of the offering to C$11 million.
The deal is expected to close Nov. 17. Additional details on the sale will be released at the closing, according to Resverlogix president and chief executive officer Donald McCaffery.
The offering was first announced on Oct. 6.
Resverlogix, based in Calgary, Alta., is a biotechnology company focused on the development of biopharmaceuticals.
| Issuer: | Resverlogix Corp.
|
| Issue: | Stock
|
| Amount: | C$9 million
|
| Shares: | 3 million shares
|
| Price: | C$3
|
| Warrants: | No
|
| Placement agent: | First Associates Investments Inc., Haywood Securities Inc., Sprott Securities Inc. and Jennings Capital Inc.
|
| Announcement date: | Oct. 6
|
| Updated: | Nov. 5
|
| Settlement date: | Nov. 17
|
| Stock price: | $3.65 at close Oct. 6
|
| Stock price: | $3.40 at close Nov. 4
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
